SARI Screening Tool

Last updated

SARI Screening Tool also known as the SARI score is a tool developed by the Ministry of Health in the Kingdom of Saudi Arabia. [1] It is a visual triage used to identify those with the potential to have COVID-19. [2] The tools was also used to screen for MERS. It has been modified multiple times and the weights of each symptom have been changed over time as well.[ citation needed ]

Related Research Articles

<span class="mw-page-title-main">Triage</span> Emergency medical process

In medicine, triage is a process by which care providers such as medical professionals and those with first aid knowledge determine the order of priority for providing treatment to injured individuals and/or inform the rationing of limited supplies so that they go to those who can most benefit from it. Triage is usually relied upon when there are more injured individuals than available care providers, or when there are more injured individuals than supplies to treat them.

<span class="mw-page-title-main">Contact tracing</span> Finding and identifying people in contact with someone with an infectious disease

In public health, contact tracing is the process of identifying people who may have been exposed to an infected person ("contacts") and subsequent collection of further data to assess transmission. By tracing the contacts of infected individuals, testing them for infection, and isolating or treating the infected, this public health tool aims to reduce infections in the population. In addition to infection control, contact tracing serves as a means to identify high-risk and medically vulnerable populations who might be exposed to infection and facilitate appropriate medical care. In doing so, public health officials utilize contact tracing to conduct disease surveillance and prevent outbreaks. In cases of diseases of uncertain infectious potential, contact tracing is also sometimes performed to learn about disease characteristics, including infectiousness. Contact tracing is not always the most efficient method of addressing infectious disease. In areas of high disease prevalence, screening or focused testing may be more cost-effective.

Healthline Media, Inc. is an American website and provider of health information headquartered in San Francisco, California. It was founded in 1999, relaunched in 2006, and established as a standalone entity in January 2016. Healthline has been ranked towards the middle of top-ranking health information websites. A study of top-ranking health websites published in 2021 evaluated its quality as "good", compared to MedlinePlus's "excellent" scores and Medical News Today's "fair/good" ranking.

<span class="mw-page-title-main">Ministry of Health (Saudi Arabia)</span> Saudi Arabian ministry of Health

The Ministry of Health, commonly abbreviated to MoH, is the ministry overseeing the health care and health policy of Saudi Arabia. The ministry is tasked with formulating strategies to ensure public health in the country, while also managing crucial health infrastructure.

<span class="mw-page-title-main">COVID-19 testing</span> Diagnostic testing for SARS-CoV-2 virus infection

COVID-19 testing involves analyzing samples to assess the current or past presence of SARS-CoV-2, the virus that cases COVID-19 and is responsible for the COVID-19 pandemic. The two main types of tests detect either the presence of the virus or antibodies produced in response to infection. Molecular tests for viral presence through its molecular components are used to diagnose individual cases and to allow public health authorities to trace and contain outbreaks. Antibody tests instead show whether someone once had the disease. They are less useful for diagnosing current infections because antibodies may not develop for weeks after infection. It is used to assess disease prevalence, which aids the estimation of the infection fatality rate.

<span class="mw-page-title-main">COVID-19 pandemic in Saudi Arabia</span>

The COVID-19 pandemic in Saudi Arabia is part of the worldwide pandemic of coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2. The first case in the kingdom was confirmed by the Ministry of Health on 2 March 2020 and in the following months, the kingdom held the highest number of confirmed cases in the Arab states of the Persian Gulf.

<span class="mw-page-title-main">COVID-19 vaccine</span> Vaccine against SARS-CoV-2

A COVID‑19 vaccine is a vaccine intended to provide acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID‑19).

The COVID-19 pandemic in Maldives was a part of the worldwide pandemic of coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2. The virus was confirmed to have spread to Maldives on 7 March 2020 from a 69-year-old Italian tourist who had returned to Italy after spending holidays in Kuredu Resort & Spa. The Health Protection Agency of Maldives confirmed two cases in Maldives, both employees of the resort. Following this, the hotel was locked down with several tourists stranded on the island. As of 11 March, the resorts of Kuredu, Vilamendhoo, Batalaa, and Kuramathi island were also placed under temporary quarantine. Schools were closed as a precaution.

The COVID-19 pandemic was confirmed to have reached Somalia on 16 March 2020 when the first case was confirmed in Mogadishu. The Somali Prime Minister, Hassan Ali Khaire announced that the government has set aside five million dollars to deal with the disease. The Somali Medical Association is concerned that the death toll in the country will be huge and that Somalia will not be able to recover from the economic effects due to poor working relations between central government and federal states which leads to lack of control by central government, as well and the lack of healthcare infrastructure. It has also been speculated that President Mohamed Abdullahi Mohamed may use the pandemic as an excuse to postpone elections. There have also been concerns over freedom of the press following arrests and intimidation of journalists who have been covering the pandemic in Somalia.

The COVID-19 pandemic in Niger is part of the ongoing worldwide pandemic of coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2. The virus was confirmed to have reached Niger in March 2020. Amnesty International reported that journalists have been arrested over reporting about the pandemic.

The COVID-19 pandemic in Mauritania was a part of the worldwide pandemic of coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2. The COVID-19 pandemic was confirmed to have reached Mauritania in March 2020.

The first case of the COVID-19 pandemic in the Indian state of Karnataka was confirmed on 8 March 2020. Two days later, the state became the first in India to invoke the provisions of the Epidemic Diseases Act, 1897, which was set to last for a year, to curb the spread of the disease. As of 25 October 2022, Karnataka has 40,01,655 confirmed cases and 40,097 deaths. with 39,52,381 recoveries and 9,135 active cases.

<span class="mw-page-title-main">Exposure Notification</span> Initiative for mobile device-based privacy-preserving contact tracing

The (Google/Apple) Exposure Notification System (GAEN) is a framework and protocol specification developed by Apple Inc. and Google to facilitate digital contact tracing during the COVID-19 pandemic. When used by health authorities, it augments more traditional contact tracing techniques by automatically logging close approaches among notification system users using Android or iOS smartphones. Exposure Notification is a decentralized reporting protocol built on a combination of Bluetooth Low Energy technology and privacy-preserving cryptography. It is an opt-in feature within COVID-19 apps developed and published by authorized health authorities. Unveiled on April 10, 2020, it was made available on iOS on May 20, 2020 as part of the iOS 13.5 update and on December 14, 2020 as part of the iOS 12.5 update for older iPhones. On Android, it was added to devices via a Google Play Services update, supporting all versions since Android Marshmallow.

<span class="mw-page-title-main">Zoe Health Study</span> COVID-19 mobile research app

The Zoe Health Study, formerly the COVID Symptom Study, is a health research project of British company Zoe Limited which uses a mobile app that runs on Android and iOS.

<span class="mw-page-title-main">Impact of the COVID-19 pandemic on other health issues</span> Health consequences of outbreak beyond the COVID-19 disease itself

The COVID-19 pandemic has had many impacts on global health beyond those caused by the COVID-19 disease itself. It has led to a reduction in hospital visits for other reasons. There have been 38 per cent fewer hospital visits for heart attack symptoms in the United States and 40 per cent fewer in Spain. The head of cardiology at the University of Arizona said, "My worry is some of these people are dying at home because they're too scared to go to the hospital." There is also concern that people with strokes and appendicitis are not seeking timely treatment. Shortages of medical supplies have impacted people with various conditions.

<span class="mw-page-title-main">COVID Alert</span> Canadian contact-tracing app for COVID-19

COVID Alert was the Exposure Notification service app for the country of Canada. It launched in the province of Ontario on July 31, 2020, and became available in nearly all Canadian provinces by October of that year, excluding Alberta, and British Columbia.

Rehabilitation after COVID-19 is needed in individuals experiencing longer-term disabling illness at any stage of COVID-19 infection. The rehabilitation of individuals with COVID-19 includes screening for the need for rehabilitation, participation of a multi-disciplinary team to evaluate and manage the individual's disabilities, use of four evidence based classes for rehabilitation, as well as individualised interventions for other problems.

<span class="mw-page-title-main">COVID-19 vaccination in mainland China</span> Plan to immunize against COVID-19


COVID-19 vaccination in mainland China is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in mainland China, in response to the ongoing pandemic in the region.

SafePass is a digital contact tracing app used as a response against the COVID-19 pandemic in the Philippines.

<span class="mw-page-title-main">Nirmatrelvir/ritonavir</span> Antiviral combination medication

Nirmatrelvir/ritonavir, sold under the brand name Paxlovid, is a co-packaged medication used as a treatment for COVID‑19. It contains the antiviral medications nirmatrelvir and ritonavir and was developed by Pfizer. Nirmatrelvir inhibits SARS-CoV-2 main protease, while ritonavir is a strong CYP3A inhibitor, slowing down nirmatrelvir metabolism and therefore boosting its effect. It is taken by mouth.

References

  1. AlGhalyini, Baraa; Shakir, Ismail; Wahed, Muaz; Babar, Sultan; Mohamed, Mohamed (30 June 2022). "Does SARI Score Predict COVID-19 Positivity? A Retrospective Analysis of Emergency Department Patients in a Tertiary Hospital" (PDF). Journal of Health and Allied Sciences. 13: 077–082. doi:10.1055/s-0042-1748806. S2CID   250189262 . Retrieved 1 July 2022.
  2. "Coronavirus Disease COVID-19 Guidelines Version 2.0" (PDF). Covid19.cdc.gov.sa. Retrieved 23 July 2022.